To hear about similar clinical trials, please enter your email below
Trial Title:
Hypnosis: a Path to Appeasement
NCT ID:
NCT05942885
Condition:
Hematologic Cancer
Conditions: Official terms:
Hematologic Neoplasms
Conditions: Keywords:
hypnosis
Diffuse large cell B-cell lymphoma
follicular lymphoma
anxiety
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Basic Science
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
anxiety questionnaire
Description:
Patient undergoing hypnosis session will have their anxiety measured just before the
third session of hypnosis and after during a telephonic consultation. The result will be
compared to the anxiety level before the first hypnosis session
Arm group label:
Anxiety scores
Summary:
Hypnosis is a technique allowing the patient to focus his mental attention on a thought
or a sensation, with the aim of reducing or modulating the intensity of a negative
feeling or an ordeal encountered during the course of treatment. This tool can be used
when patients are faced with chronic disorders (pain, anxiety, ...) or iatrogenic effects
(nausea, asthenia, ...).
The patient is referred to hypnosis care by the doctor, psychologist or paramedics who
follow him, when they detect a need.
Several scientific studies have shown the effectiveness of hypnosis in improving the
quality of life of patients with breast cancer and in reducing pain during invasive
procedures. On the other hand, in hematology, no research has measured the evolution of
anxiety, over time, in patients receiving hypnotherapy.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Patients over 18 years old, fluent in French.
- Patients starting hypnotherapy for anxiety disorders.
- Anxiety score on the HADS scale (Hospital Anxiety and Depression Scale) greater than
or equal to 8/21
- Patients with diffuse large cell B-cell lymphoma or follicular lymphoma, whatever
the stage of the disease.
- Diagnosis announcement less than 2 months old
Exclusion Criteria:
- Persons deprived of their liberty by a judicial or administrative decision
- Adults subject to a legal protection measure
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Service MB1 - Hôpital Lyon Sud - HCL
Address:
City:
Lyon
Zip:
69495
Country:
France
Status:
Recruiting
Contact:
Last name:
Thomas Bert
Phone:
04.78.86.43.45
Email:
thomas.bert01@chu-lyon.fr
Start date:
October 30, 2023
Completion date:
July 30, 2025
Lead sponsor:
Agency:
Hospices Civils de Lyon
Agency class:
Other
Source:
Hospices Civils de Lyon
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05942885
